CYTOKINETICS INC (CYTK)

US23282W6057 - Common Stock

70.185  -1.22 (-1.72%)

News Image
3 days ago - Cytokinetics, Incorporated

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session

SOUTH SAN FRANCISCO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the...

News Image
8 days ago - The Motley Fool

2 Incredible Growth Stocks to Buy Right Now

These two biotech stocks could be big winners in the years ahead.

News Image
10 days ago - InvestorPlace

7 Biotech Stocks Ready to Ride the Sector’s Resurgence

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.

News Image
15 days ago - InvestorPlace

7 Biotech Stocks to Buy as Sector Rotation Ramps Up

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

News Image
17 days ago - Market News Video

Cytokinetics is Now Oversold (CYTK)

News Image
24 days ago - Cytokinetics, Incorporated

Cytokinetics to Participate in March Investor Conferences

SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled...

News Image
a month ago - Investor's Business Daily

Super Micro, Deckers To Join S&P 500 Index

They'll replace Whirlpool and Zions Bancorp on March 18.

News Image
a month ago - Cytokinetics, Incorporated

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 29, 2024 it...

News Image
a month ago - Cytokinetics, Incorporated

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

SOUTH SAN FRANCISCO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is joining the European...

News Image
a month ago - Cytokinetics, Incorporated

Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials

Grant Funding Provided by Cytokinetics to Each Organization to Help Increase Clinical Trial Engagement Among Historically Underrepresented Groups...

News Image
a month ago - Seeking Alpha

Cytokinetics GAAP EPS of -$1.38 misses by $0.39, revenue of $1.67M misses by $11.59M (NASDAQ:CYTK)

Cytokinetics reports Q4 financial results with a GAAP EPS miss and revenue decrease.

News Image
a month ago - Cytokinetics, Incorporated

Cytokinetics Reports Fourth Quarter 2023 Financial Results

Topline Results from SEQUOIA-HCM Announced in DecemberShowed Statistically Significant and Clinically Meaningful Increasein Primary Efficacy Endpoint and...

News Image
a month ago - Cytokinetics, Incorporated

Cytokinetics to Announce Fourth Quarter Results on February 27, 2024

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report...

News Image
a month ago - Seeking Alpha

Cytokinetics stock seesaws as CEO says not conducting a sales process

Cytokinetics (CYTK) experiences volatility as its CEO states the company is not actively undergoing a sales process but remaining receptive to discussions.

News Image
2 months ago - InvestorPlace

3 Biotech Stocks to Buy for the Next Bull Run: February 2024

These are the biotech stocks to buy that you must have on your watchlist for the coming bull run. It could get started as soon as this month.

News Image
2 months ago - Investor's Business Daily

How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month

Cytokinetics is looking to take on Bristol Myers Squibb in treating a heart disease.

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President...

News Image
2 months ago - Seeking Alpha

Cytokinetics stock weakness buying opportunity, Truist says

Cytokinetics' CFO resignation sparks a 2.2% drop in stock; Truist analyst sees it as a buying opportunity due to personal health reasons cited by CEO.

News Image
2 months ago - Market News Video

Notable Friday Option Activity: WYNN, IMVT, CYTK

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program

Total of $100,000 Awarded to Five Patient Advocacy Organizations to Support Communications and Community Outreach...

News Image
2 months ago - InvestorPlace

3 Healthcare Stocks at 52-Week Lows: Buy or Bye?

Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten

New Data Show Treatment with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy Resulted in Favorable Structural Remodeling, Improvements...

News Image
2 months ago - Seeking Alpha

UBS cuts Cytokinetics to neutral, sees takeout valuation at $105 (NASDAQ:CYTK)

UBS has downgraded Cytokinetics (CYTK) to neutral, commenting that it believes some of the potential M&A premium has already been baked into the stock’s price. Read more here.

News Image
2 months ago - Cytokinetics, Incorporated

Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

SOUTH SAN FRANCISCO, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced an upcoming presentation at CMR...